Early stroke and systemic embolism rates in patients following cardioversion for atrial fibrillation (A-fib) are low and comparable between those receiving warfarin or the novel oral anticoagulant ...
ANKARA, TURKEY — A strategy that takes advantage of the C in ICD (implantable cardioverter defibrillator), in which the device delivers a shock aimed at restoring sinus rhythm in patients with atrial ...
ENSURE-AF: Edoxaban noninferior to standard anticoagulation before cardioversion in patients with AF
Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation undergoing cardioversion, edoxaban conferred similar outcomes to the ...
The authors caution in the report that the trial was "underpowered to provide statistically rigorous results and was thus exploratory in nature." To heartwire,Cappato said an adequately powered trial ...
PRINCETON, N.J. & NEW YORK--Bristol-Myers Squibb Company and Pfizer Inc. today announced that the first patient has been enrolled into a Phase IV clinical trial called EMANATE (Eliquis evaluated in ...
Please provide your email address to receive an email when new articles are posted on . PARIS — Cardioversion with maximum-fixed energy shocks was more effective than low-escalating energy shocks for ...
Delay in correcting atrial fibrillation irregular cardiac rhythm linked with increased complications
A delay of 12 hours or longer to correct an abnormal cardiac rhythm from atrial fibrillation was associated with a greater risk of thromboembolic complications such as stroke, according to a study. A ...
A heart shock may restore the heart’s rhythm and is a potential treatment for atrial fibrillation (AFib). Doctors also refer to heart shock as electrical cardioversion. In AFib, a person has an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results